Request Deal Involvement
URUS completed the acquisition of Trans Ova Genetics from Precigen for $180m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Davis Polk & Wardwell
financial advisors
Rabobank
pr advisors
Finn Partners
legal advisors
Morgan Lewis & Bockius
or
Principals
target
TRANS OVA GENETICS
vendor
PRECIGEN
bidder
URUS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite